<DOC>
	<DOCNO>NCT01272596</DOCNO>
	<brief_summary>Impairment visual deficit , particular contrast acuity contrast impairment frequent symptom MS . However , visual function appropriately covered standard tool clinical assessment , namely , EDSS MSFC . The primary aim study investigate , whether MS patient contrast acuity sensitivity change period two year . Secondary aim correlation visual contrast parameter structural retinal change quality life .</brief_summary>
	<brief_title>Evaluation Sloan-Charts Assessment Disease Progress Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Clinically Isolated Syndrome definite MS ( relapsingremitting secondary progressive course ) Written Informed Consent Relapse within last 30 Days Significant Cognitive Impairment Severely Decreased Visual Acuity Preexisting Severe Retinal Pathology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Visual Contrast Acuity</keyword>
	<keyword>Visual Contrast Sensitivity</keyword>
	<keyword>Sloan Charts</keyword>
</DOC>